Sandoz Canada


A Canadian division focused on development, manufacture, and commercialization of generic and biosimilar medicines, with capabilities in quality systems, supply chain management, product launches, medical information, and community engagement through grants and sponsorships.

Industries

N/A

Sandoz Canada


Products

Generic small-molecule medicines portfolio

A portfolio of approved generic medicines across multiple therapeutic categories marketed in Canada.

Biosimilars portfolio

A portfolio of biosimilar medicines intended to offer alternatives to reference biologics in therapeutic areas covered in Canada.

Specialty medicines portfolio

Products categorized as specialty medicines managed alongside generics and biosimilars.

Sitagliptin and sitagliptin–metformin generic products

Recently launched generic versions of sitagliptin and a sitagliptin–metformin combination for glucose management.


Services

Medical information services

Provides a medical inquiry channel for healthcare professionals and patients to request clinical and safety information about marketed medicines.

Grants, donations and sponsorship program

Administration of corporate philanthropy and community sponsorships in Canada.

Customer and commercial support (Canada)

National contact and office network to support commercial operations and customer service within Canada.

Expertise Areas

  • Generic medicine development and commercialization
  • Biosimilar development and market access
  • GMP manufacturing and quality assurance
  • Supply chain and distribution logistics
  • Show More (3)

Key Technologies

  • GMP manufacturing
  • Biologics/biopharmaceutical manufacturing
  • Small-molecule formulation
  • Analytical chemistry and impurity testing
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.